Myomo (MYO) Non-Current Deffered Revenue (2017 - 2023)
Myomo (MYO) reported Non-Current Deffered Revenue of $126.0 for Q2 2023, down 86.51% on a YoY basis from $934.0 in Q2 2022, and down 59.62% quarter-over-quarter from $312.0 in Q1 2023.
Myomo (MYO) Non-Current Deffered Revenue (2017 - 2023) Analysis & Trends
Myomo has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $126.0 in Q2 2023.
- For the quarter ending Q2 2023, Non-Current Deffered Revenue fell 86.51% year-over-year to $126.0; the trailing twelve-month figure through Jun 2023 stood at $126.0 (down 86.51% YoY), and the FY2022 full-year result was $498.0, down 60.03% from the prior year.
- Non-Current Deffered Revenue for Q2 2023 stood at $126.0, down from $312.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $133976.0 in Q3 2019, with the low at $126.0 in Q2 2023.
- Historically, Non-Current Deffered Revenue has averaged $9886.8 across 5 years, with a median of $1495.0 in 2019.
- The largest YoY upside for Non-Current Deffered Revenue was 53705.62% in 2019 against a maximum downside of 98.97% in 2019.
- Myomo's Non-Current Deffered Revenue stood at $1495.0 in 2019, then changed by 0.0% to $1495.0 in 2020, then dropped by 16.66% to $1246.0 in 2021, then sank by 60.03% to $498.0 in 2022, then slumped by 74.7% to $126.0 in 2023.
- The last three Non-Current Deffered Revenue figures came in at $126.0 (Q2 2023), $312.0 (Q1 2023), and $498.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Myomo | 45.01 Mn | 26.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 126.00 |
| Mar 31, 2023 | 312.00 |
| Dec 31, 2022 | 498.00 |
| Sep 30, 2022 | 685.00 |
| Jun 30, 2022 | 934.00 |
| Mar 31, 2022 | 1,246.00 |
| Dec 31, 2021 | 1,246.00 |
| Sep 30, 2021 | 1,495.00 |
| Jun 30, 2021 | 1,495.00 |
| Mar 31, 2021 | 1,495.00 |
| Dec 31, 2020 | 1,495.00 |
| Sep 30, 2020 | 1,495.00 |
| Jun 30, 2020 | 8,700.00 |
| Mar 31, 2020 | 1,495.00 |
| Dec 31, 2019 | 1,495.00 |
| Sep 30, 2019 | 133,976.00 |
| Dec 31, 2018 | 144,582.00 |
| Sep 30, 2018 | 249.00 |
| Jun 30, 2018 | 45,496.00 |
| Mar 31, 2018 | 45,496.00 |